Daclatasvir for hepatitis C: Added benefit not proven

The data is unsuitable for virus genotype 4 patients and for untreated genotype 1 patients without cirrhosis; there is no data for genotype 3 patients and three other genotype 1 groups. —> Read More Here


Leave a Reply

Your email address will not be published. Required fields are marked *